Pfizer Inc. (PFE) 13D/13G Filings for Enliven Therapeutics, Inc. (ELVN)

Pfizer Inc. 13D and 13G filings for Enliven Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2024-02-14
3:31 pm
Sale
2023-12-3113GENLIVEN THERAPEUTICS INC
ELVN
PFIZER INC
PFE
389,429
0.950%
-1,168,293decrease
(-75.00%)
Filing